These parameters were developed by the Joint Task Force on Practice Parameters,
representing the American Academy of Allergy, Asthma & Immunology; the American College of …

This document builds on the previous Joint Task Force document ‘‘Allergen immunotherapy:
a practice parameter second update’’published in the Journal of Allergy and Clinical …

When drug reactions resembling allergy occur, they are called drug hypersensitivity reactions
( DHR s) before showing the evidence of either drug‐specific antibodies or T cells. DHR s …

These parameters were developed by the Joint Task Force on Practice Parameters,
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American …

The major emphasis of this updated version of Practice Parameters for Allergy Diagnostic
Testing is focused on how technological refinements and their validations during the past …

These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP),
representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the …

Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a
wide range of clinical manifestations. Severe anaphylaxis and/or the need for repeated …

These parameters were developed by the Joint Task Force on Practice Parameters, representing
the American Academy of Allergy, Asthma and Immunology; the American College of …

… by S pneumoniae, H influenzae, and M catarrhalis. Both M catarrhalis and H influenzae
can produce β-lactamase and thereby be resistant to penicillin and its derivatives. A …

KELSO ET AL 27 allergy. Only for patients with a history of allergic reaction to influenza
vaccine itself is additional evaluation appropriate, including skin testing with the vaccine and …